Emerging Engineered Nanoweapons for Tumors

Authors

  • V. Bhatia
  • H. Vij

DOI:

https://doi.org/10.37591/rrjooh.v1i2.1358

Abstract

Cancer is a type of disease characterized by abnormal growth of cells which tend to proliferate in uncontrolled manner. It occurs at molecular level when genes undergo genetic alterations. The malignant growth of tumor cells results in non-functioning of the concerned organ. Over the years, cancer targeting technique has greatly improved by new approaches based on nanotechnology. Nanotechnology is helpful in development of new therapies against cancer. Nanotechnology is a boon for diagnosis, treatment and prevention of cancer disease. The most challenging task, i.e., targeting of the desired drug to the tumor tissues is a major area of concern today. Several nanobiotechnologies mostly based on nanoparticles have been used to facilitate drug delivery in cancer. There are various tools in the field of nanotechnology which can be used to treat cancer, such as gold nanoparticles, nanofibers, nanopores, nanoshells and nanotubes. Gold and nanotechnology are in the age of innovation. Nanotechnology-based cancer treatment approaches provide localized targeted therapies that aim to enhance efficacy, reduce side effects and improve patient’s life. The basic approach of this review is to discuss the new defining features of cancer technology with the help of nanotechnology, by which we can evade cancerous cells.

 

Keywords: Nanotechnology, cancer, nanomedicine, gold nanoparticle

Downloads

Published

2019-04-12

Issue

Vol. 1 No. 2 (2012)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.